People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. | — | Biotechnology | Series B | $19.2M | $160.4M | 2019 |
Simon X. Benito at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Simon X. Benito on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lota S Zoth | 1 | 4 |
| Wendy L Yarno | 1 | 3 |
| Ann C. Miller | 1 | 2 |
| Peter Jospeh Kies | 1 | 1 |
| Angel X. Cabrera | 1 | 1 |
| Jacqueline S. Shea | 1 | 1 |
| David B. Weiner | 1 | 1 |
| Jay X. Shepard | 1 | 1 |
| Morton X. Collins | 1 | 1 |
| Laurent S. Humeau | 1 | 1 |
| J. Jospeh Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.